CVS HEALTH Corp (CVS) KPIs and segments
Close on Nov 17, 2026Market cap $109.75BP/E 22.8Yield 3.10%
KPI & bộ phận
Chỉ số vận hành và bộ phận làm nên hoạt động của Cvs Health · năm tài chính kết thúc ngày 31 tháng 12
Nhìn nhanh KPI của Cvs Health: 46 chỉ số vận hành, trong đó có Health Care Benefits (Aetna), Health Care Benefits và Health Care Benefits, lấy từ 359 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.
Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.
Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.
| Thêm vào biểu đồ | Chỉ số | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Health Services($M) | 51,795 | 48,237 | 51,244 | 49,266 | 46,453 | 43,462 | 47,020 | 44,129 | 42,171 | 40,285 | 49,146 | ||
Health Care Benefits($M) | 37,538 | 35,971 | 36,293 | 35,993 | 36,258 | 34,810 | 32,958 | 32,996 | 32,475 | 32,236 | 26,726 | ||
Pharmacy & Consumer Wellness($M) | 33,816 | 31,989 | 37,660 | 36,214 | 33,581 | 31,912 | 33,514 | 32,423 | 29,838 | 28,725 | 31,185 | ||
Products($M) | 66,219 | 62,226 | 67,042 | 64,590 | 60,607 | 57,669 | 61,911 | 59,674 | 56,212 | 53,724 | 65,154 | ||
Services($M) | 4,119 | 3,835 | 4,040 | 3,930 | 3,626 | 3,579 | 4,131 | 4,279 | 3,961 | 3,868 | 3,316 | ||
Health Care Benefits($M) | 2,426 | 3,041 | -676 | 314 | 1,308 | 1,993 | -439 | -924 | 938 | 732 | 676 | ||
Health Services($M) | 1,733 | 1,489 | 1,923 | 2,050 | 1,575 | 1,603 | 1,761 | 2,204 | 1,915 | 1,363 | 1,860 | ||
Pharmacy & Consumer Wellness($M) | 1,475 | 1,197 | 1,911 | 1,478 | 1,338 | 1,313 | 1,758 | 1,596 | 1,243 | 1,177 | 2,027 | ||
Health Care Benefits($M) | 37,538 | 35,971 | 36,293 | 35,993 | 36,258 | 34,810 | 32,958 | 32,996 | 32,475 | 32,236 | |||
Pharmacy & Consumer Wellness($M) | 6,534 | 6,199 | 7,082 | 6,567 | 6,027 | 6,108 | 6,804 | 6,391 | 6,003 | 5,965 | |||
Health Services($M) | 3,887 | 3,518 | 4,035 | 4,036 | 3,373 | 3,347 | 3,662 | 3,748 | 3,406 | 2,753 | |||
Stores1 | |||||||||||||
Pharmacy & Consumer Wellness | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | |||||
Health Care Benefits (Aetna) — Total Medical Membership7 | 26,023.00 | 26,005.00 | 26,591.00 | 26,703.00 | 26,721.00 | 27,079.00 | 27,095.00 | 27,148.00 | 26,970.00 | 26,770.00 | 25,659.00 | ||
Total Insured Medical Membership | 9,829.00 | 9,767.00 | 10,868.00 | 11,001.00 | 11,069.00 | 11,417.00 | 12,514.00 | 12,557.00 | 12,428.00 | 12,212.00 | 11,128.00 | ||
Total ASC (Self-Insured) Medical Membership | 16,194.00 | 16,238.00 | 15,723.00 | 15,702.00 | 15,652.00 | 15,662.00 | 14,581.00 | 14,591.00 | 14,542.00 | 14,558.00 | 14,531.00 | ||
Commercial Medical Membership (Total)2 | 18,320.00 | 18,334.00 | 18,797.00 | 18,850.00 | 18,859.00 | 19,211.00 | 18,851.00 | 18,906.00 | 18,801.00 | 18,846.00 | 18,339.00 | ||
Commercial — Insured | 2,487.00 | 2,462.00 | 3,447.00 | 3,536.00 | 3,608.00 | 3,961.00 | 4,691.00 | 4,751.00 | 4,702.00 | 4,735.00 | 4,252.00 | ||
Commercial — ASC | 15,833.00 | 15,872.00 | 15,350.00 | 15,314.00 | 15,251.00 | 15,250.00 | 14,160.00 | 14,155.00 | 14,099.00 | 14,111.00 | 14,087.00 | ||
Medicare Advantage Medical Membership (Insured / Total) | 4,202.00 | 4,175.00 | 4,267.00 | 4,266.00 | 4,240.00 | 4,220.00 | 4,447.00 | 4,438.00 | 4,342.00 | 4,205.00 | 3,460.00 | ||
Medicare Supplement Membership (Insured / Total) | 1,176.00 | 1,192.00 | 1,202.00 | 1,221.00 | 1,236.00 | 1,253.00 | 1,282.00 | 1,291.00 | 1,294.00 | 1,300.00 | 1,343.00 | ||
Medicaid Medical Membership (Total)2 | 2,325.00 | 2,304.00 | 2,325.00 | 2,366.00 | 2,386.00 | 2,395.00 | 2,515.00 | 2,513.00 | 2,533.00 | 2,419.00 | 2,517.00 | ||
Medicaid — Insured | 1,964.00 | 1,938.00 | 1,952.00 | 1,978.00 | 1,985.00 | 1,983.00 | 2,094.00 | 2,077.00 | 2,090.00 | 1,972.00 | 2,073.00 | ||
Medicaid — ASC | 361.00 | 366.00 | 373.00 | 388.00 | 401.00 | 412.00 | 421.00 | 436.00 | 443.00 | 447.00 | 444.00 | ||
Medicare Part D Standalone Prescription Drug Plan (PDP) Membership | 3,870.00 | 3,889.00 | 4,041.00 | 4,056.00 | 4,065.00 | 4,094.00 | 4,882.00 | 4,898.00 | 4,903.00 | 4,947.00 | 6,081.00 | ||
Health Care Benefits — Medical Benefit Ratio (MBR %)(%) | 87.4% | 84.6% | 94.8% | 92.8% | 89.9% | 87.3% | 94.8% | 95.2% | 89.6% | 90.4% | 88.5% | ||
Health Care Benefits — Days Claims Payable (DCP, days)(ngày) | 42 | 43 | 39 | 43 | 41 | 43 | 44 | 45 | 43 | 45 | 46 | ||
Health Services (Caremark PBM) — Pharmacy Claims Processed (30-Day Equivalent)(M) | 473 | 465 | 492 | 476 | 469 | 464 | 499 | 484 | 471 | 463 | 601 | ||
Health Services (Caremark PBM) — Generic Dispensing Rate (Total %, through FY2024)(%) | 86.1% | 86.8% | 88.2% | 88.3% | 86.2% | ||||||||
Pharmacy & Consumer Wellness (CVS Pharmacy) — Prescriptions Filled (30-Day Equivalent)(M)2 | 457 | 451 | 474 | 461 | 438 | 436 | 446 | 432 | 420 | 418 | 432 | ||
Same-Store Prescription Volume Growth (%, 30-Day Equivalent)(%) | 7.0% | 6.8% | 9.7% | 8.9% | 6.4% | 6.7% | 5.9% | 9.1% | 6.5% | 5.8% | 4.4% | ||
Pharmacy & Consumer Wellness — Generic Dispensing Rate (%, through FY2024)(%) | 87.4% | 88.2% | 90.1% | 90.1% | 86.6% | ||||||||
Pharmacy & Consumer Wellness — Total Same-Store Sales Growth (% YoY)(%)2 | 2.6% | 2.8% | 16.0% | 14.3% | 15.4% | 14.2% | 10.2% | 15.5% | 6.4% | 5.3% | 11.3% | ||
Pharmacy Same-Store Sales Growth (% YoY)(%) | 2.9% | 3.1% | 19.3% | 16.8% | 18.1% | 17.7% | 13.0% | 19.5% | 9.1% | 7.3% | 15.5% | ||
Front Store Same-Store Sales Growth (% YoY)(%) | 1.0% | 1.2% | 0.5% | 1.5% | 3.4% | -0.3% | -1.2% | -1.1% | -4.0% | -2.2% | -3.1% | ||
Health Care Benefits (Aetna) — Total Segment Revenues($M)2 | 37,538 | 35,971 | 36,293 | 35,993 | 36,258 | 34,810 | 32,958 | 32,996 | 32,475 | 32,236 | 26,726 | ||
Health Care Benefits — Premium Revenues (Total)($M)2 | 35,119 | 33,792 | 34,018 | 33,739 | 34,184 | 32,808 | 30,902 | 30,914 | 30,654 | 30,379 | 25,065 | ||
Government Premiums (Medicare Advantage, Medicare Supplement, PDP & Medicaid)($M) | 28,494 | 27,783 | 26,562 | 25,968 | 25,930 | 24,902 | 22,164 | 22,331 | 22,222 | 21,716 | 17,414 | ||
Commercial Insured Premiums($M) | 6,625 | 6,009 | 7,456 | 7,771 | 8,254 | 7,906 | 8,738 | 8,583 | 8,432 | 8,663 | 7,651 | ||
Health Care Benefits — Net Investment Income($M) | 508 | 462 | 475 | 513 | 407 | 387 | 397 | 423 | 300 | 353 | 209 | ||
Health Care Benefits — Adjusted Operating Income (Loss)($M)6 | 2,426 | 3,041 | -676 | 314 | 1,308 | 1,993 | -439 | -924 | 938 | 732 | 676 | ||
Health Care Benefits — Adjusted Operating Margin (%)(%) | 6.5% | 8.5% | -1.9% | 0.9% | 3.6% | 5.7% | -1.3% | -2.8% | 2.9% | 2.3% | 2.5% | ||
Health Care Benefits — GAAP Operating Income (Loss)($M) | 2,191 | 2,806 | -936 | 53 | 1,002 | 1,674 | -757 | -1,229 | 574 | 428 | 266 | ||
Health Care Benefits — GAAP Operating Margin (%)(%) | 5.8% | 7.8% | -2.6% | 0.1% | 2.8% | 4.8% | -2.3% | -3.7% | 1.8% | 1.3% | 1.0% | ||
Health Care Benefits — Health Care Costs (Benefit Costs)($M) | 30,692 | 28,579 | 32,253 | 31,319 | 30,740 | 28,637 | 29,300 | 29,443 | 27,458 | 27,458 | 22,175 | ||
Health Care Benefits — Operating Expenses($M) | 4,655 | 4,586 | 4,976 | 4,621 | 4,516 | 4,499 | 4,415 | 4,782 | 4,443 | 4,350 | 4,285 | ||
Health Care Benefits — Operating Expense Ratio (% of Revenues)(%) | 12.4% | 12.7% | 13.7% | 12.8% | 12.5% | 12.9% | 13.4% | 14.5% | 13.7% | 13.5% | 16.0% | ||
Health Services (Caremark PBM & Care Delivery) — Total Segment Revenues($M)4 | 51,795 | 48,237 | 51,244 | 49,266 | 46,453 | 43,462 | 47,020 | 44,129 | 42,171 | 40,285 | 49,146 | ||
Health Services Revenue by Channel — Pharmacy Network($M) | 26,617 | 25,149 | 27,588 | 26,408 | 24,665 | 23,114 | 25,202 | 24,136 | 21,848 | 20,464 | 29,668 | ||
Health Services Revenue by Channel — Mail & Specialty (Mail Choice)($M) | 22,577 | 20,506 | 21,263 | 20,392 | 19,611 | 18,068 | 18,750 | 17,214 | 17,651 | 17,262 | 17,614 | ||
Health Services Revenue by Channel — Net Investment Income (Loss)($M) | -1 | 10 | -1 | -3 | 14 | 288 | -1 | -2 | -1 | ||||
Health Services Revenue by Source — Services($M) | 2,580 | 2,511 | 2,432 | 2,500 | 2,233 | 2,313 | 2,713 | 2,922 | 2,681 | 2,568 | 1,910 | ||
Health Services — Adjusted Operating Income($M)9 | 1,733 | 1,489 | 1,923 | 2,050 | 1,575 | 1,603 | 1,761 | 2,204 | 1,915 | 1,363 | 1,860 | ||
Health Services — Adjusted Operating Margin (%)(%) | 3.3% | 3.1% | 3.8% | 4.2% | 3.4% | 3.7% | 3.7% | 5.0% | 4.5% | 3.4% | 3.8% | ||
Health Services — GAAP Operating Income($M) | 1,603 | 1,347 | 1,790 | -3,899 | 1,102 | 1,227 | 1,903 | 2,055 | 1,766 | 1,213 | 1,710 | ||
Health Services — GAAP Operating Margin (%)(%) | 3.1% | 2.8% | 3.5% | -7.9% | 2.4% | 2.8% | 4.0% | 4.7% | 4.2% | 3.0% | 3.5% | ||
Health Services — Gross Profit($M) | 2,537 | 2,216 | 2,640 | 2,745 | 2,272 | 2,300 | 2,683 | 2,812 | 2,615 | 2,052 | 2,535 | ||
Health Services — Gross Margin (%)(%) | 4.9% | 4.6% | 5.2% | 5.6% | 4.9% | 5.3% | 5.7% | 6.4% | 6.2% | 5.1% | 5.2% | ||
Health Services — Cost of Products Sold($M) | 47,908 | 44,719 | 47,209 | 45,230 | 43,080 | 40,115 | 43,358 | 40,381 | 38,765 | 37,532 | 45,999 | ||
Health Services — Health Care Costs (Oak Street Capitated Medical Costs)($M) | 1,350 | 1,302 | 1,395 | 1,291 | 1,101 | 1,047 | 979 | 936 | 791 | 701 | 612 | ||
Health Services — Operating Expenses($M) | 934 | 869 | 850 | 919 | 1,170 | 1,073 | 780 | 757 | 849 | 839 | 825 | ||
Health Services — Operating Expense Ratio (% of Revenues)(%) | 1.8% | 1.8% | 1.7% | 1.9% | 2.5% | 2.5% | 1.7% | 1.7% | 2.0% | 2.1% | 1.7% | ||
Pharmacy & Consumer Wellness (CVS Pharmacy) — Total Segment Revenues($M)4 | 33,816 | 31,989 | 37,660 | 36,214 | 33,581 | 31,912 | 33,514 | 32,423 | 29,838 | 28,725 | 31,185 | ||
Pharmacy & Consumer Wellness Revenue by Line — Pharmacy($M) | 27,781 | 26,123 | 31,375 | 30,428 | 27,631 | 26,076 | 27,224 | 26,666 | 24,013 | 22,784 | 24,740 | ||
Pharmacy & Consumer Wellness Revenue by Line — Front Store($M) | 5,407 | 5,259 | 5,656 | 5,192 | 5,368 | 5,243 | 5,675 | 5,196 | 5,281 | 5,370 | 5,861 | ||
Pharmacy & Consumer Wellness Revenue by Source — Products($M) | 33,152 | 31,339 | 36,845 | 35,503 | 32,942 | 31,285 | 32,833 | 31,823 | 29,252 | 28,120 | 30,534 | ||
Pharmacy & Consumer Wellness Revenue by Source — Services($M) | 664 | 650 | 815 | 711 | 639 | 627 | 681 | 600 | 586 | 605 | 652 | ||
Pharmacy & Consumer Wellness — Adjusted Operating Income($M)6 | 1,475 | 1,197 | 1,911 | 1,478 | 1,338 | 1,313 | 1,758 | 1,596 | 1,243 | 1,177 | 2,027 | ||
Pharmacy & Consumer Wellness — Adjusted Operating Margin (%)(%) | 4.4% | 3.7% | 5.1% | 4.1% | 4.0% | 4.1% | 5.2% | 4.9% | 4.2% | 4.1% | 6.5% | ||
Pharmacy & Consumer Wellness — GAAP Operating Margin (%)(%) | 4.2% | 3.5% | 4.9% | 3.9% | 2.2% | 2.7% | 5.1% | 2.4% | 4.0% | 3.9% | 6.3% | ||
Pharmacy & Consumer Wellness — Gross Margin (%)(%) | 19.3% | 19.4% | 18.8% | 18.1% | 17.9% | 19.1% | 20.3% | 19.7% | 20.1% | 20.8% | 22.6% | ||
Pharmacy & Consumer Wellness — Cost of Products Sold($M) | 27,282 | 25,790 | 30,578 | 29,647 | 27,554 | 25,804 | 26,710 | 26,032 | 23,835 | 22,760 | 24,146 | ||
Pharmacy & Consumer Wellness — Operating Expenses($M) | 5,123 | 5,065 | 5,236 | 5,153 | 5,291 | 5,244 | 5,110 | 4,860 | 4,824 | 4,852 | 5,078 | ||
Pharmacy & Consumer Wellness — Operating Expense Ratio (% of Revenues)(%) | 15.1% | 15.8% | 13.9% | 14.2% | 15.8% | 16.4% | 15.2% | 15.0% | 16.2% | 16.9% | 16.3% | ||
Consolidated — Adjusted Operating Income($M)3 | 5,157 | 5,150 | 2,597 | 3,459 | 3,808 | 4,579 | 2,728 | 2,547 | 3,744 | 2,957 | 4,227 | ||
Consolidated — Adjusted Income Attributable to CVS Health($M) | 3,324 | 3,292 | 1,387 | 2,037 | 2,304 | 2,844 | 1,506 | 1,369 | 2,306 | 1,657 | 2,738 | ||
Consolidated — Adjusted Diluted EPS ($/share)($) | 2.58 | 2.57 | 1.09 | 1.60 | 1.81 | 2.25 | 1.19 | 1.09 | 1.83 | 1.31 | 2.12 | ||
Consolidated — Intersegment Revenue Eliminations($M) | -17,200 | -15,897 | -19,626 | -18,735 | -17,473 | -15,729 | -15,865 | -14,262 | -13,361 | -12,924 | -13,319 | ||
Health Care Costs Payable, Net of Reinsurance (Actuarial Rollforward)($M)6 | 16,203 | 15,404 | 15,329 | 15,300 | 14,296 | 14,565 | 14,984 | 14,521 | 13,850 | 14,387 | 12,067 | ||
IBNR (Incurred But Not Reported) Claims Liability($M) | 10,600 | 10,600 | 10,600 | 10,400 | 10,700 | 11,000 | 10,600 | 11,000 | |||||
Reinsurance Recoverables on Unpaid Claims($M) | 112 | 132 | 90 | 94 | 103 | 114 | 81 | 65 | 59 | 4 | 5 | ||
Total Incurred Health Care Costs in Reserve Rollforward($M)2 | 31,404 | 29,281 | 33,704 | 32,125 | 30,803 | 28,642 | 30,131 | 29,181 | 27,782 | 27,733 | 22,450 | ||
Incurred Health Care Costs — Current Year($M) | 31,553 | 30,374 | 33,760 | 32,151 | 31,052 | 30,293 | 30,233 | 29,364 | 27,965 | 28,212 | 22,456 | ||
Incurred Health Care Costs — Prior Years Development (Favorable / Unfavorable)($M) | -149 | -1,093 | -56 | -26 | -249 | -1,651 | -102 | -183 | -183 | -479 | -6 | ||
Claims Paid — Current Year Incurred($M) | 29,752 | 18,255 | 33,336 | 30,896 | 29,479 | 19,312 | 30,227 | 28,138 | 26,955 | 16,263 | 22,577 | ||
Claims Paid — Prior Years Incurred($M) | 853 | 10,951 | 339 | 225 | 1,593 | 9,749 | -559 | 372 | 1,364 | 9,150 | 378 | ||
Health Care Costs Payable Assumed in Acquisitions / Dispositions($M) | 0 | 0 | 0 | ||||||||||
Direct Premiums Earned (Reinsurance Schedule)7 | |||||||||||||
Premiums Receivable, Net($M) | 6,395 | 7,633 | 5,753 | 4,878 | 5,885 | 6,210 | 4,731 | 3,942 | 4,430 | 5,420 | 3,714 | ||
Deferred Acquisition Costs (DAC) Balance($M)2 | 1,917 | 1,881 | 1,837 | 1,794 | 1,747 | 1,690 | 1,627 | 1,560 | 1,502 | ||||
DAC Capitalized Additions($M) | 127 | 127 | 129 | 133 | 139 | 134 | 137 | 134 | 134 | ||||
DAC Amortization Expense($M) | 91 | 83 | 86 | 86 | 82 | 71 | 70 | 76 | 69 | ||||
Statutory Capital & Surplus Required by Insurance Regulators($M) | 11,710 | 11,691 | 9,011 | ||||||||||
Maximum Statutory Dividend Capacity Without Prior Regulatory Approval($M) | 3,788 | 1,561 | 3,098 | ||||||||||
Self-Insurance Accrual Liability($M) | 1,200 | 1,100 | 1,100 | ||||||||||
Separate Account Policyholder Deposits($M) | 220 | 226 | 206 | 236 | 303 | 231 | 229 | 201 | 203 | ||||
Separate Account Policyholder Benefits Paid($M) | 239 | 241 | 230 | 243 | 272 | 257 | 226 | 223 | 224 | ||||
Available-for-Sale (AFS) Debt Securities — Fair Value($M)7 | 29,349 | 28,391 | 28,718 | 27,835 | 26,554 | 26,044 | 26,033 | 26,490 | 23,831 | 22,626 | 21,713 | ||
AFS Debt Securities — Amortized Cost($M) | 29,564 | 28,593 | 28,600 | 27,705 | 26,656 | 26,345 | 26,562 | 26,433 | 24,548 | 23,308 | 22,282 | ||
AFS Debt Securities — Gross Unrealized Gains($M) | 207 | 245 | 449 | 462 | 347 | 246 | 178 | 510 | 146 | 191 | 267 | ||
AFS Debt Securities — Gross Unrealized Losses($M) | 422 | 447 | 331 | 332 | 449 | 547 | 707 | 453 | 863 | 873 | 836 | ||
AFS Debt Securities Maturing Within 1 Year (Fair Value)($M) | 1,168 | 852 | 817 | 838 | 963 | 1,189 | 761 | 816 | 1,349 | 1,245 | 1,230 | ||
AFS Debt Securities Maturing in 1 to 5 Years (Fair Value)($M) | 11,752 | 11,534 | 11,699 | 11,512 | 11,070 | 10,670 | 10,510 | 10,529 | 8,784 | 7,836 | 7,390 | ||
AFS Debt Securities Maturing in 5 to 10 Years (Fair Value)($M) | 5,880 | 5,685 | 5,382 | 4,783 | 4,564 | 4,385 | 4,578 | 4,890 | 4,288 | 4,463 | 4,204 | ||
AFS Debt Securities Maturing After 10 Years (Fair Value)($M) | 2,978 | 2,900 | 2,847 | 2,712 | 2,561 | 2,710 | 2,909 | 3,064 | 3,310 | 3,703 | 3,802 | ||
Total Lease Cost (Note 7 Leases)1 | |||||||||||||
Undiscounted Future Operating Lease Payments (Total)($M)8 | 19,387 | 21,189 | 22,853 | ||||||||||
Operating Lease Payments Due in Year 1($M) | 2,626 | 2,683 | 2,716 | ||||||||||
Operating Lease Payments Due in Year 2($M) | 2,475 | 2,528 | 2,559 | ||||||||||
Operating Lease Payments Due in Year 3($M) | 2,300 | 2,343 | 2,369 | ||||||||||
Operating Lease Payments Due in Year 4($M) | 2,031 | 2,167 | 2,181 | ||||||||||
Operating Lease Payments Due in Year 5($M) | 1,789 | 1,911 | 2,024 | ||||||||||
Operating Lease Payments Due After Year 5($M) | 8,166 | 9,557 | 11,004 | ||||||||||
Total Finance Lease Liabilities($M) | 1,326 | 1,357 | 1,360 | 1,373 | 1,379 | 1,391 | |||||||
Finance Lease Right-of-Use Assets, Net($M) | 1,094 | 1,140 | 1,229 | ||||||||||
Long-Term Debt Maturing After Year 5 (Note 10 Borrowings)($M)5 | 43,299 | 43,558 | 41,685 | ||||||||||
Long-Term Debt Maturing in Year 1($M) | 4,007 | 3,559 | 2,705 | ||||||||||
Long-Term Debt Maturing in Year 2($M) | 3,379 | 4,007 | 3,785 | ||||||||||
Long-Term Debt Maturing in Year 3($M) | 5,008 | 3,379 | 4,008 | ||||||||||
Long-Term Debt Maturing in Year 4($M) | 3,758 | 5,007 | 3,379 | ||||||||||
Long-Term Debt Maturing in Year 5($M) | 4,258 | 3,758 | 5,007 | ||||||||||
Gross Finite-Lived & Indefinite-Lived Intangible Assets (Note 6)($M)8 | 44,365 | 44,271 | 44,166 | ||||||||||
Accumulated Amortization of Intangible Assets($M) | 18,857 | 16,948 | 14,932 | ||||||||||
Indefinite-Lived Intangible Assets (Tradenames)($M) | 10,498 | 10,498 | 10,498 | ||||||||||
Intangible Asset Amortization Expense($M) | 431 | 442 | 483 | 500 | 494 | 499 | 503 | 507 | 507 | 508 | 509 | ||
Estimated Intangible Amortization — Year 1($M) | 1,717 | 1,981 | 2,011 | ||||||||||
Estimated Intangible Amortization — Year 2($M) | 1,604 | 1,704 | 1,964 | ||||||||||
Estimated Intangible Amortization — Year 3($M) | 1,330 | 1,590 | 1,687 | ||||||||||
Estimated Intangible Amortization — Year 4($M) | 1,252 | 1,316 | 1,580 | ||||||||||
Estimated Intangible Amortization — Year 5($M) | 1,219 | 1,239 | 1,306 | ||||||||||
Trade Accounts Payable & Pharmacy Working Capital Balances($M)4 | 17,167 | 16,922 | 17,641 | 17,764 | 17,258 | 16,534 | 15,892 | 15,713 | 14,416 | 13,717 | 14,897 | ||
Contract Assets, Current (PBM Rebates & Medicare Part D)($M) | 12,985 | 12,511 | 10,563 | 11,221 | 10,465 | 10,450 | 9,881 | 9,884 | 9,793 | 10,586 | 11,908 | ||
Contract Liabilities, Current($M) | 62 | 58 | 61 | 65 | 144 | 174 | 128 | 117 | 149 | ||||
Other Receivables, Net (Manufacturer Rebates & CMS)($M) | 6,111 | 6,704 | 7,899 | 9,979 | 9,053 | 8,760 | 7,966 | 6,732 | 4,634 | 3,530 | 3,894 | ||
Allowance for Credit Losses on Accounts Receivable($M) | 169 | 200 | 182 | 178 | 374 | 392 | 407 | 346 | 355 | 402 | 343 | ||
BEA U.S. Personal Consumption Expenditures: Health Care Services (SAAR $B)5 | 3,790.30 | 3,699.90 | 3,667.00 | 3,614.90 | 3,529.80 | 3,464.70 | 3,417.80 | 3,358.20 | 3,288.20 | 3,244.40 | 3,159.40 | ||
BEA Real PCE: Health Care Quantity Index (2017=100)(×) | 135.90 | 133.60 | 133.60 | 132.70 | 130.40 | 129.00 | 127.90 | 126.70 | 124.80 | 123.80 | 121.50 | ||
Census QSS Quarterly Revenue: Ambulatory Health Care Services (NAICS 621)($M) | 414,886 | 395,174 | 407,176 | 398,164 | 389,960 | 373,423 | 380,950 | 366,854 | 362,208 | 347,178 | 347,128 | ||
Census QSS Quarterly Revenue: Hospitals (NAICS 622)($M) | 47,896 | 46,674 | 46,834 | 46,295 | 45,370 | 45,358 | 45,284 | 43,778 | 43,505 | 43,709 | 43,264 | ||
Census QSS Quarterly Revenue: Medical and Diagnostic Laboratories (NAICS 6215)($M) | 20,528 | 19,569 | 19,997 | 19,677 | 19,718 | 18,722 | 19,104 | 18,893 | 18,483 | 17,963 | 17,943 | ||
Census QSS Quarterly Revenue: Outpatient Care Centers (NAICS 6214)($M) | 45,108 | 44,022 | 45,300 | 42,797 | 41,832 | 40,030 | 40,602 | 37,897 | 37,227 | 36,087 | 37,030 | ||
Peer Benchmark — UnitedHealth Group (UNH): Total Revenues($M)4 | 112,032 | 111,721 | 113,215 | 113,161 | 111,616 | 109,575 | 100,807 | 100,820 | 98,855 | 99,796 | 94,427 | ||
UnitedHealth Group (UNH) — Premiums Revenue($M) | 86,956 | 87,561 | 88,811 | 88,979 | 87,905 | 86,534 | 76,483 | 77,442 | 76,897 | 77,988 | 73,228 | ||
UnitedHealth Group (UNH) — Medical & Policyholder Benefits Expense($M) | 75,358 | 73,489 | 82,041 | 79,958 | 78,585 | 73,411 | 67,035 | 65,957 | 65,458 | 65,735 | 62,231 | ||
UnitedHealth Group (UNH) — GAAP Operating Income($M) | 7,991 | 8,990 | 380 | 4,315 | 5,150 | 9,119 | 7,773 | 8,708 | 7,875 | 7,931 | 7,689 | ||
UnitedHealth Group (UNH) — Medical Costs Payable($M) | 38,930 | 39,659 | 39,337 | 40,181 | 38,427 | 37,136 | 34,224 | 33,951 | 32,547 | 34,032 | 32,395 | ||
Peer Benchmark — The Cigna Group (CI / Express Scripts): Total Revenues($M)3 | 71,668 | 68,494 | 72,472 | 69,748 | 67,178 | 65,502 | 65,649 | 63,694 | 60,523 | 57,255 | 51,114 | ||
The Cigna Group (CI) — Premiums Revenue($M) | 9,859 | 9,812 | 9,288 | 9,081 | 9,156 | 12,736 | 11,503 | 11,436 | 11,454 | 11,603 | 11,175 | ||
The Cigna Group (CI) — Medical & Policyholder Benefits Expense($M) | 8,430 | 7,924 | 8,260 | 7,842 | 7,749 | 10,498 | 10,166 | 9,527 | 9,515 | 9,440 | 9,280 | ||
The Cigna Group (CI) — GAAP Operating Income($M) | 2,676 | 2,358 | 2,345 | 2,578 | 2,306 | 1,971 | 2,173 | 2,576 | 2,412 | 2,256 | 2,060 | ||
Peer Benchmark — Elevance Health (ELV / Carelon, through Q3 2026): Total Revenues($M)4 | 51,429 | 50,474 | 50,181 | 49,747 | 50,711 | 49,776 | 48,891 | 45,442 | 45,106 | 43,886 | 42,577 | 42,647 | |
Elevance Health (ELV) — Premiums Revenue($M) | 41,704 | 41,279 | 41,024 | 40,690 | 41,791 | 41,271 | 40,887 | 36,245 | 36,809 | 35,416 | 35,696 | 35,138 | |
Elevance Health (ELV) — Benefit Expense($M) | 37,779 | 37,024 | 35,615 | 38,065 | 38,140 | 36,706 | 35,312 | 33,500 | 32,949 | 30,572 | 30,546 | 31,334 | |
Elevance Health (ELV) — GAAP Operating Income($M) | 1,269 | 1,763 | 2,086 | 309 | 1,295 | 2,425 | 3,170 | 673 | 1,408 | 2,765 | 3,016 | 1,284 | |
Elevance Health (ELV) — Medical Claims Payable($M) | 18,438 | 18,463 | 18,425 | 17,084 | 17,148 | 17,155 | 16,812 | 15,746 | 15,346 | 15,204 | 16,459 | 16,111 | |
Peer Benchmark — Humana Inc. (HUM / CenterWell): Total Revenues($M)4 | 39,648 | 32,515 | 32,649 | 32,388 | 32,112 | 29,213 | 29,397 | 29,540 | 29,611 | 26,462 | |||
Humana Inc. (HUM) — Premiums Revenue($M) | 37,709 | 30,884 | 30,711 | 30,716 | 30,514 | 27,750 | 27,951 | 28,142 | 28,261 | 25,128 | |||
Humana Inc. (HUM) — Benefits Expense($M) | 33,707 | 28,721 | 27,991 | 27,565 | 26,535 | 25,381 | 25,120 | 25,039 | 25,124 | 22,782 | |||
Humana Inc. (HUM) — GAAP Operating Income($M) | 1,754 | -808 | 400 | 1,098 | 2,014 | -543 | 728 | 1,141 | 1,236 | -348 | |||
Humana Inc. (HUM) — Benefits Payable($M) | 12,691 | 9,967 | 10,088 | 11,060 | 11,451 | 10,440 | 11,125 | 11,446 | 11,729 | 10,241 | |||
Peer Benchmark — Centene Corporation (CNC, through Q3 2026): Total Revenues($M)3 | 50,647 | 53,579 | 49,944 | 49,725 | 49,690 | 48,742 | 46,620 | 40,805 | 42,023 | 39,836 | 40,407 | 39,460 | |
Centene Corporation (CNC) — Medical Costs($M) | 41,128 | 39,029 | 38,303 | 41,489 | 40,902 | 38,808 | 36,503 | 31,809 | 32,201 | 30,765 | 30,932 | 30,634 | |
Centene Corporation (CNC) — GAAP Operating Income($M) | -307 | 1,198 | 1,861 | -1,745 | -6,954 | -458 | 1,534 | 175 | 665 | 1,229 | 1,106 | -194 | |
Centene Corporation (CNC) — Medical Claims Liability($M) | 21,495 | 20,262 | 20,627 | 20,544 | 21,493 | 20,117 | 19,911 | 18,308 | 17,995 | 18,173 | 18,109 | 18,000 | |
Peer Benchmark — Molina Healthcare (MOH, through Q3 2026): Total Revenues($M)3 | 11,082 | 10,874 | 10,796 | 11,375 | 11,477 | 11,427 | 11,147 | 10,499 | 10,340 | 9,880 | 9,931 | 9,048 | |
Molina Healthcare (MOH) — Premium Revenue($M) | 10,457 | 10,244 | 10,172 | 10,715 | 10,841 | 10,868 | 10,628 | 9,983 | 9,694 | 9,446 | 9,504 | 8,362 | |
Molina Healthcare (MOH) — GAAP Operating Income($M) | 106 | 145 | 83 | -162 | 137 | 373 | 433 | 380 | 467 | 434 | 426 | 316 | |
Molina Healthcare (MOH) — Medical Claims & Benefits Payable($M) | 4,988 | 4,841 | 4,941 | 4,887 | 4,844 | 4,885 | 4,804 | 4,640 | 4,732 | 4,577 | 4,571 | 4,204 | |
Peer Benchmark — HCA Healthcare (HCA) & Labcorp (LH): Provider & Lab Revenues($M)2 | 19,109 | 19,513 | 19,161 | 18,605 | 18,321 | 18,285 | 17,487 | 17,492 | 17,339 | 17,303 | |||
Labcorp Holdings (LH) — Total Revenues($M) | 3,731 | 3,538 | 3,516 | 3,564 | 3,527 | 3,345 | 3,329 | 3,282 | 3,221 | 3,177 | 3,033 | ||
Labcorp Holdings (LH) — GAAP Operating Income($M) | 452 | 381 | 268 | 397 | 394 | 326 | 216 | 254 | 295 | 321 | -123 | ||
DB Segment Context — Health Care Benefits Segment Revenue($M)1 | 37,538 | 35,971 | 36,293 | 35,993 | 36,258 | 34,810 | 32,958 | 32,996 | 32,475 | 32,236 | 26,726 | ||
DB Segment — Health Care Benefits D&A($M) | 348 | 340 | 380 | 375 | 419 | 405 | 403 | 407 | 397 | 392 | |||
DB Segment Context — Health Services (formerly Pharmacy Services) Segment Revenue($M)1 | 51,795 | 48,237 | 51,244 | 49,266 | 46,453 | 43,462 | 47,020 | 44,129 | 42,171 | 40,285 | 49,146 | ||
DB Segment — Health Services D&A($M) | 251 | 258 | 258 | 260 | 260 | 261 | 267 | 267 | 264 | 261 | |||
DB Segment Context — Pharmacy & Consumer Wellness (formerly Retail/LTC) Segment Revenue($M)1 | 33,816 | 31,989 | 37,660 | 36,214 | 33,581 | 31,912 | 33,514 | 32,423 | 29,838 | 28,725 | 31,185 | ||
DB Segment — Pharmacy & Consumer Wellness D&A($M) | 415 | 406 | 404 | 396 | 389 | 384 | 379 | 387 | 389 | 388 | |||
DB Consolidated — Total Revenues($M)11 | 106,096 | 100,426 | 105,693 | 102,871 | 98,915 | 94,588 | 97,710 | 95,428 | 91,234 | 88,437 | 93,813 | ||
DB Consolidated — Net Investment Income($M) | 641 | 574 | 594 | 632 | 487 | 520 | 755 | 550 | 394 | 454 | 268 | ||
DB Consolidated — Cost of Revenue($M) | 58,862 | 55,444 | 59,060 | 57,045 | 54,005 | 51,057 | 55,268 | 52,948 | 49,998 | 48,073 | 57,419 | ||
DB Consolidated — Policyholder & Medical Benefits($M) | 31,485 | 29,358 | 33,066 | 32,020 | 31,317 | 29,135 | 29,543 | 29,922 | 27,853 | 27,803 | 22,518 | ||
DB Consolidated — Operating Income (GAAP)($M) | 4,703 | 4,680 | 2,112 | -3,207 | 2,381 | 3,374 | 2,368 | 832 | 3,045 | 2,271 | 3,373 | ||
DB Consolidated — Interest Expense($M) | 757 | 774 | 787 | 784 | 763 | 785 | 758 | 752 | 732 | 716 | 690 | ||
DB Consolidated — Income Before Income Taxes($M) | 3,977 | 3,938 | 1,354 | -3,482 | 1,647 | 2,617 | 2,126 | 105 | 2,337 | 1,580 | 2,705 | ||
DB Consolidated — Income Tax Provision($M) | 982 | 981 | -1,569 | 508 | 634 | 835 | 503 | 34 | 569 | 456 | 658 | ||
DB Consolidated — Net Income Attributable to CVS Health($M) | 2,979 | 2,943 | 2,943 | -3,975 | 1,021 | 1,779 | 1,644 | 87 | 1,770 | 1,113 | 2,046 | ||
DB Consolidated — Diluted EPS (GAAP)($) | 2.31 | 2.30 | -3.13 | 0.80 | 1.41 | 0.07 | 1.41 | 0.88 | |||||
DB Consolidated — Weighted Average Diluted Shares(M) | 1,287 | 1,279 | 1,269 | 1,270 | 1,264 | 1,259 | 1,259 | 1,267 | |||||
DB Consolidated — Cash Dividends Declared per Share($) | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.60 | ||
DB Consolidated Balance Sheet — Total Assets($M)11 | 253,768 | 252,974 | 253,538 | 255,327 | 258,343 | 255,585 | 253,215 | 252,427 | 252,481 | 249,743 | 249,728 | ||
DB Balance Sheet — Accounts Receivable, Net($M) | 40,309 | 40,992 | 39,779 | 43,857 | 40,651 | 39,625 | 36,469 | 36,179 | 32,385 | 32,217 | 35,227 | ||
DB Balance Sheet — Inventories($M) | 17,622 | 17,770 | 19,246 | 18,962 | 17,447 | 17,385 | 18,107 | 17,649 | 16,068 | 16,346 | 18,025 | ||
DB Balance Sheet — Property and Equipment, Net($M) | 13,168 | 13,037 | 13,083 | 12,838 | 12,825 | 12,856 | 12,993 | 12,728 | 13,032 | 13,037 | 13,183 | ||
DB Balance Sheet — Operating Lease Right-of-Use Assets($M) | 14,451 | 14,741 | 14,973 | 15,271 | 15,512 | 15,704 | 15,944 | 16,231 | 16,901 | 17,045 | 17,252 | ||
DB Balance Sheet — Goodwill($M) | 85,478 | 85,478 | 85,478 | 85,478 | 91,203 | 91,203 | 91,272 | 91,272 | 91,272 | 91,272 | 91,272 | ||
DB Balance Sheet — Intangible Assets, Net($M) | 24,644 | 25,070 | 25,508 | 25,984 | 26,224 | 26,570 | 27,323 | 27,817 | 28,311 | 28,770 | 29,234 | ||
DB Balance Sheet — Accrued Expenses and Other Liabilities($M) | 22,477 | 22,258 | 22,387 | 23,415 | 23,101 | 22,369 | 20,810 | 20,174 | 21,163 | 22,350 | 23,515 | ||
DB Balance Sheet — Operating Lease Liabilities($M) | 15,380 | 16,650 | 17,775 | ||||||||||
DB Balance Sheet — Total Liabilities($M) | 173,869 | 175,337 | 178,156 | 182,217 | 180,792 | 178,475 | 177,485 | 177,321 | 177,370 | 175,593 | 173,092 | ||
DB Balance Sheet — Total Shareholders' Equity($M) | 79,899 | 77,637 | 75,382 | 73,110 | 77,551 | 77,110 | 75,730 | 75,106 | 75,111 | 74,150 | 76,636 | ||
DB Balance Sheet — Common Shares Outstanding(M) | 1,278 | 1,273 | 1,271 | 1,270 | 1,267 | 1,262 | 1,260 | 1,258 | 1,256 | 1,252 | 1,288 | ||
DB Consolidated Cash Flow — Operating Cash Flow($M)6 | 6,345 | 4,249 | 3,390 | 796 | 1,897 | 4,556 | 1,860 | -745 | 3,089 | 4,903 | -2,636 | ||
DB Cash Flow — Capital Expenditures (Additions to Property & Equipment)($M) | 691 | 849 | 784 | 698 | 607 | 743 | 768 | 670 | 638 | 705 | 911 | ||
DB Cash Flow — Depreciation and Amortization($M) | 1,126 | 1,115 | 1,147 | 1,134 | 1,171 | 1,154 | 1,147 | 1,161 | 1,151 | 1,138 | 1,134 | ||
DB Cash Flow — Stock-Based Compensation($M) | 176 | 266 | 135 | 138 | 136 | 126 | 137 | 133 | 133 | 137 | 127 | ||
DB Cash Flow — Acquisitions (Net of Cash Acquired)($M) | 4 | 5 | 7 | 290 | 119 | 20 | 10 | 12 | 48 | 25 | 120 | ||
DB Cash Flow — Dividends Paid($M) | 878 | 847 | 845 | 846 | 866 | 840 | 838 | 837 | 858 | 840 | 779 | ||
DB Cash Flow — Share Repurchases($M) | -0 | -0 | -0 | -0 | -0 | 1 | 3 | 3,027 | 1 | ||||
91 chỉ số không có số liệu trong 12 quý gần nhất — .
In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).
Phương pháp và các chỉ số bị loại
- Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
- Fiscal calendar: CVS Health Corporation operates on a calendar fiscal year ending December 31 (Q1 ends Mar 31, Q2 ends Jun 30, Q3 ends Sep 30, Q4 ends Dec 31). Latest reported company period: Q2 2026 (ended June 30, 2026, filed August 5, 2026 on Form 8-K and Form 10-Q) and Full-Year FY2025 (ended December 31, 2025, filed February 10, 2026 on Form 8-K and Form 10-K). Industry monthly FRED series extend through September 2026 (2026-09) and Managed Care peer XBRL benchmarks (ELV, CNC, MOH) extend through Q3 2026 (FY2026Q3).
- Q1 2023 Segment Realignment: Effective Q1 2023, CVS Health realigned its segments into Health Care Benefits (Aetna), Health Services (formerly Pharmacy Services, adding Oak Street Health, Signify Health, and MinuteClinic care delivery), and Pharmacy & Consumer Wellness (formerly Retail/LTC, adding mail/specialty fulfillment support and discontinuing the former Maintenance Choice segment reporting practice). Comparative FY2021–FY2022 figures were retrospectively recast in the FY2023 Form 8-K/10-K.
- Discontinuation of Generic Dispensing Rate (GDR %): Beginning Q1 2025, CVS Health discontinued reporting Generic Dispensing Rate (GDR %) in both Health Services and Pharmacy & Consumer Wellness. Historical GDR series are preserved continuously from FY2017 through FY2024Q4 / FY2024.
- Subsidiary Self-Reported Disclosures (Group 3): Integrates standalone SEC Form 10-K and Form 10-Q filings of Oak Street Health, Inc. (CIK 0001564406, acquired May 2, 2023), Signify Health, Inc. (CIK 0001828182, acquired March 29, 2023), and Aetna Inc. (CIK 0001122304, acquired November 28, 2018).
- Parent-Company Standalone Evaluation (Step 3): CVS Health files consolidated US GAAP financial statements without standalone parent-company revenue/operating statements (parent registrant is a holding company with $0 direct operating revenue). Therefore, Consolidated − Standalone subtraction does not apply.
- Strict Step 4 & Step 5 Compliance: Every cell displays an exact point figure published by CVS Health, its subsidiaries (Oak Street Health, Signify Health, Aetna), or official industry sources (CMS Medicaid Managed Care Enrollment Reports, Census/BLS/BEA via FRED, SEC XBRL peer filings), plus permitted period splits (Q4 = full year − nine months and quarterly cash flow = YTD − prior YTD, marked with formula). Bound/approximate prose figures ('approximately 9,000 retail locations', 'more than 81% of MA members in 4+ star plans' in FY2025, 'more than 3.5 million IHEs', 'approximately 500,000 patients') are excluded and cataloged in `excluded`.
Không hiện vì thiếu các kỳ gần đây (13)
- Retail pharmacy locations count in Item 1 narrative ('approximately 9,000 retail locations' / 'more than 7,000 retail stores') — Approximate figures ('approximately 9,000', 'more than 7,000') — excluded from table cells; replaced with exact figures from the Store Development Activity table in Item 7 MD&A (8,979 stores at end of FY2025).
- Retail stores net selling space ('approximately 71.3 million square feet') & distribution centers space ('approximately 10.0 million square feet') — Approximate figures ('approximately 71.3 million', 'approximately 10.0 million') — excluded.
- Retail pharmacies within chains ('approximately 1,870') and clinics in Target stores ('approximately 30') — Approximate figures ('approximately 1,870', 'approximately 30') from FY2019 onward; state breakdown table only reports data points through FY2017.
- Medicare Advantage 4.0+ Star plan membership share in FY2025 ('more than 81%' in 4+ star plans; 'more than 63%' in 4.5-star plans) — Approximate figures for FY2025 ('more than 81%', 'more than 63%') — FY2025 data point excluded; exact series retained for FY2015–FY2024 (88% in FY2024, 87% in FY2023).
- Oak Street Health patients cared for in FY2024–FY2025 ('approximately 500,000 patients') and FY2023 ('approximately 270,000 patients') — Approximate figures ('approximately 500,000', 'approximately 270,000') post-merger into CVS — excluded; exact patient count series retained from Oak Street Health's standalone 10-K/10-Q filings (FY2018–FY2023Q1: 231,000 patients).
- Signify Health in-home health evaluations (IHEs) volume ('more than 3.5 million IHEs' in FY2025; 'more than 3 million' in FY2024) — Approximate figures ('more than 3.5 million') — excluded; exact Evaluations revenue retained from Signify Health's 10-K/10-Q filings.
- U.S. retail pharmacy prescription market share ('approximately 28.5%' in FY2025 10-K; 'exceeding 29%' in Q4 2025 presentation) — Approximate figures ('approximately 28.5%', 'exceeding 29%') — excluded.
- PBM plan members ('approximately 87 million plan members') and retail network size ('approximately 63,000 retail pharmacies') — Approximate figures ('approximately 87 million', 'approximately 63,000') — excluded.
- Walk-in and primary care medical clinics ('more than 1,000 clinics' / 'more than 800 MinuteClinic locations') — Approximate figures ('more than 1,000', 'more than 800') — excluded.
- Total workforce headcount ('over 300,000 colleagues', 'approximately 73% full-time') and training hours ('approximately 16 million hours') — Approximate figures ('over 300,000', 'approximately 73%', 'approximately 16 million') — excluded.
- Health Services retail co-payments included in segment revenue ('approximately $2.1 billion' in Q4 2025; '$10.9 billion' in FY2025) — Approximate figures ('approximately $2.1 billion') in footnotes — excluded.
- Full-Year 2026 Guidance ranges (Revenues 'At least $414.0B', Adjusted EPS '$7.90 to $8.10', Medical Membership '~26.0M', MBR '89.75% ±25 bps') — Approximate figures / forward-looking guidance ranges ('At least', '~', 'to', '±') — recorded in footnotes & README, excluded from reported actuals.
- YTD 6-month and 9-month cumulative segment columns in Q2 and Q3 Form 8-K / 10-Q tables — 6-month / 9-month cumulative figures — table fully displays each discrete quarter (Q1, Q2, Q3, Q4) and full year (FY).
Dữ liệu cập nhật 2026-10-28.
Mỗi KPI một trang riêng
Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số
1. Core Operational KPIs — Aetna Membership & MBR, Caremark PBM Claims, CVS Pharmacy Rx & Store Footprint
- Health Care Benefits (Aetna) — Total Medical Membership31 kỳ
- Health Care Benefits — Medical Benefit Ratio (MBR %) (%)30 kỳ
- Health Care Benefits — Days Claims Payable (DCP, days) (ngày)30 kỳ
- Health Services (Caremark PBM) — Pharmacy Claims Processed (30-Day Equivalent) (M)32 kỳ
- Health Services (Caremark PBM) — Generic Dispensing Rate (Total %, through FY2024) (%)26 kỳ
- Health Services (Oak Street Health) — Value-Based Primary Care Centers Operated8 kỳ
- Pharmacy & Consumer Wellness (CVS Pharmacy) — Prescriptions Filled (30-Day Equivalent) (M)32 kỳ
- Pharmacy & Consumer Wellness — Total Same-Store Sales Growth (% YoY) (%)32 kỳ
- Pharmacy & Consumer Wellness — Total Retail & Chain Pharmacy Locations at Year-End9 kỳ
2. Disaggregated Segment Revenues, Channel Mix & Adjusted Profitability (8-K / 10-Q / 10-K Supplemental)
- Health Care Benefits (Aetna) — Total Segment Revenues ($M)32 kỳ
- Health Care Benefits — Adjusted Operating Income (Loss) ($M)32 kỳ
- Health Services (Caremark PBM & Care Delivery) — Total Segment Revenues ($M)32 kỳ
- Health Services — Adjusted Operating Income ($M)32 kỳ
- Pharmacy & Consumer Wellness (CVS Pharmacy) — Total Segment Revenues ($M)32 kỳ
- Pharmacy & Consumer Wellness — Adjusted Operating Income ($M)32 kỳ
- Consolidated — Adjusted Operating Income ($M)32 kỳ
3. Acquired Subsidiaries Self-Reported Disclosures — Oak Street Health, Signify Health & Pre-Merger Aetna
4. Actuarial Claims Rollforward, Statutory Capital, AFS Investments, Store Leases & Governance (XBRL & DEF 14A)
- Health Care Costs Payable, Net of Reinsurance (Actuarial Rollforward) ($M)32 kỳ
- Direct Premiums Earned (Reinsurance Schedule) ($M)8 kỳ
- Available-for-Sale (AFS) Debt Securities — Fair Value ($M)30 kỳ
- Total Lease Cost (Note 7 Leases) ($M)7 kỳ
- Long-Term Debt Maturing After Year 5 (Note 10 Borrowings) ($M)8 kỳ
- Gross Finite-Lived & Indefinite-Lived Intangible Assets (Note 6) ($M)13 kỳ
- Trade Accounts Payable & Pharmacy Working Capital Balances ($M)32 kỳ
- Customer Experience — MIP Net Promoter Score (NPS) Performance vs. Target (%) (%)3 kỳ
5. CMS Medicaid Managed Care Enrollment — U.S. National Totals & 19 CVS/Aetna State Plans
6. Industry Macro Indicators (Census Pharmacy Sales, BLS CPI/PPI/Employment) & Managed Care Peers (through Sep / Q3 2026)
- U.S. Census Retail Sales: Pharmacies and Drug Stores (Seasonally Adjusted, Monthly through Aug 2026) ($M)128 kỳ
- BEA U.S. Personal Consumption Expenditures: Health Care Services (SAAR $B)42 kỳ
- BLS CPI: Prescription Drugs in U.S. City Average (1982-84=100, Monthly through Sep 2026) (×)0 kỳ
- BLS Employment: Health Care and Social Assistance (Monthly through Sep 2026)129 kỳ
- Peer Benchmark — UnitedHealth Group (UNH): Total Revenues ($M)42 kỳ
- Peer Benchmark — The Cigna Group (CI / Express Scripts): Total Revenues ($M)38 kỳ
- Peer Benchmark — Elevance Health (ELV / Carelon, through Q3 2026): Total Revenues ($M)43 kỳ
- Peer Benchmark — Humana Inc. (HUM / CenterWell): Total Revenues ($M)41 kỳ
- Peer Benchmark — Centene Corporation (CNC, through Q3 2026): Total Revenues ($M)43 kỳ
- Peer Benchmark — Molina Healthcare (MOH, through Q3 2026): Total Revenues ($M)43 kỳ
- Peer Benchmark — HCA Healthcare (HCA) & Labcorp (LH): Provider & Lab Revenues ($M)21 kỳ
7. Consolidated Financial Statements & Segment Context (PostgreSQL DB via lib.db)
- DB Segment Context — Health Care Benefits Segment Revenue ($M)34 kỳ
- DB Segment Context — Health Services (formerly Pharmacy Services) Segment Revenue ($M)46 kỳ
- DB Segment Context — Pharmacy & Consumer Wellness (formerly Retail/LTC) Segment Revenue ($M)46 kỳ
- DB Consolidated — Total Revenues ($M)46 kỳ
- DB Consolidated Balance Sheet — Total Assets ($M)46 kỳ
- DB Consolidated Cash Flow — Operating Cash Flow ($M)46 kỳ
Tài liệu nguồn mới nhất
Các tài liệu được trích nhiều nhất cho số liệu mới nhất của Cvs Health
- CVS Health 10-Q (2026-08-05) ↗
- CVS Health 10-K (2026-02-10) ↗
- CVS Health DB Segment (10-Q 2026-08-05) ↗
- CVS Health DB Segment (10-K 2026-02-10) ↗
- CVS Health DB (10-Q 2026-08-05) ↗
- CVS Health DB (10-K 2026-02-10) ↗
- CVS Health 8-K (2026-08-05) ↗
- OSH 10-Q (2023-05-09) ↗
- Signify Health SEC 10-K (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax) ↗
- CVS SEC 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet) ↗
- CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
- CVS SEC 10-K (XBRL us-gaap:LeaseCost) ↗
See a number that looks wrong?